Clinical Drug Experience Knowledgebase

agomelatine (Valdoxan) (1 trial)

Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (4 trials)

basiliximab (Simulect) (1 trial)

bortezomib (velcade) (6 trials)

decitabine (dacogen) (14 trials)

dexamethasone (4 trials)

dexmedetomidine (precedex) (1 trial)

doxorubicin (Doxil) (3 trials)

etoposide (vepesid) (1 trial)

exenatide (byetta) (2 trials)

glimepiride (amaryl) (1 trial)

idebenone (2 trials)

methylcantharidimide (1 trial)

oseltamivir (tamiflu) (1 trial)

propofol (diprivan) (2 trials)

reduning (1 trial)

rosuvastatin (crestor) (1 trial)

ruxolitinib (jakafi) (3 trials)

sargramostim (leukine) (8 trials)

saxagliptin (onglyza) (1 trial)

selegiline (zelapar) (1 trial)

sitagliptin (januvia) (3 trials)

somatropin (protropin) (3 trials)

tocilizumab (actemra) (1 trial)

urea (3 trials)

vancomycin (Vancocin) (1 trial)

vedolizumab (entyvio) (1 trial)

131i-lipiodol (Lipiodol) (1 trial)

acetylcysteine (mucomyst) (5 trials)

acetylsalicylic acid (aspirin) (1 trial)

aclarubicin (4 trials)

alteplase (Activase) (2 trials)

aminophylline (aminophyllin) (1 trial)

anlotinib (2 trials)

autologous mesenchymal stem cell-derived neural progenitors (1 trial)

autologous umbilical cord blood (1 trial)

avatrombopag (2 trials)

azacitidine (vidaza) (22 trials)

busulfan (Myleran) (4 trials)

capecitabine (xeloda) (2 trials)

carboplatin (paraplatin) (2 trials)

cetuximab (erbitux) (1 trial)

ciltacabtagene autoleucel (Carvykti) (5 trials)

cisplatin (platinol) (7 trials)

cladribine (leustatin) (4 trials)

clarithromycin (biaxin) (1 trial)

cyclophosphamide (cytoxan) (14 trials)

cyclosporine (sandimmune) (1 trial)

cytarabine (cytosar-u) (15 trials)

daunorubicin (cerubidine) (1 trial)

docetaxel (taxotere) (2 trials)

eltrombopag (promacta) (3 trials)

Epimedium (1 trial)

epirubicin (ellence) (1 trial)

epoetin (Epogen) (2 trials)

Filgrastim (neupogen) (8 trials)

fludarabine (fludara) (6 trials)

fluorouracil (efudex) (4 trials)

gefitinib (iressa) (3 trials)

gelatin (1 trial)

gemcitabine (gemzar) (2 trials)

hetrombopag olamine (2 trials)

idarubicin (idamycin) (4 trials)

irinotecan (Camptosar) (2 trials)

lenalidomide (revlimid) (4 trials)

mitoxantrone (novantrone) (3 trials)

mycophenolate (CellCept) (1 trial)

nedaplatin (1 trial)

neuregulin (1 trial)

omacetaxine (synribo) (5 trials)

paclitaxel (taxol) (2 trials)

platelets (1 trial)

Raltitrexed (Tomudex) (1 trial)

rasagiline (azilect) (1 trial)

Relmapirazin (1 trial)

semustine (1 trial)

sodium chloride (2 trials)

sorafenib (nexavar) (1 trial)

thrombopoietin (4 trials)

tretinoin (Retin-A) (2 trials)

venetoclax (venclexta) (17 trials)

vinorelbine (navelbine) (3 trials)

visilizumab (1 trial)

abatacept (orencia) (1 trial)

abiraterone (zytiga) (2 trials)

ak117 (1 trial)

aldesleukin (Proleukin) (4 trials)

allogeneic hematopoietic stem cells (Hemacord) (1 trial)

anti-flt3 car-t (1 trial)

autologous cd19/cd22 chimeric antigen receptor t-cells (5 trials)

autologous hematopoietic stem cells (1 trial)

avapritinib (Ayvakit) (1 trial)

b7-h3 car-t (1 trial)

bacille calmette-guerin (1 trial)

bat4406f (1 trial)

bcma-pd1-cart cell (1 trial)

belumosudil (Rezurock) (1 trial)

bevacizumab (avastin) (2 trials)

blinatumomab (blincyto) (2 trials)

bn104 (1 trial)

calcium (1 trial)

car-t targeted cd19/cd20/cd22/cd30 (1 trial)

cd19 car-t cells (11 trials)

cd38 car-t cells (1 trial)

cd7 car-t cell (3 trials)

chidamide (8 trials)

cll-1 cart-t cell (1 trial)

darolutamide (Nubeqa) (1 trial)

deferasirox (exjade) (1 trial)

endostatin (endostar) (3 trials)

ensartinib (1 trial)

erlotinib (tarceva) (1 trial)

flumatinib (1 trial)

gimeracil (2 trials)

hlx10 (1 trial)

house dust mite allergen (1 trial)

humanized cd19 car-t cells with crs suppression technology (1 trial)

inotuzumab ozogamicin (besponsa) (1 trial)

interferon alfa-1b (Rebif) (1 trial)

kn046 (1 trial)

lapatinib (tykerb) (2 trials)

letermovir (prevymis) (1 trial)

leucovorin (1 trial)

lm-305 (1 trial)

Nelonemdaz (1 trial)

nimotuzumab (1 trial)

niraparib (zejula) (1 trial)

obinutuzumab (gazyva) (2 trials)

Olverembatinib (3 trials)

orelabrutinib (2 trials)

oteracil (2 trials)

oxaliplatin (eloxatin) (2 trials)

pamiparib (1 trial)

prednisone (meticorten) (4 trials)

rituximab (rituxan) (5 trials)

s-1 (1 trial)

selinexor (Xpovio) (3 trials)

sintilimab (4 trials)

stro-001 (1 trial)

stromal vascular fraction (1 trial)

tegafur (2 trials)

temozolomide (temodar) (1 trial)

thymalfasin (zadaxin) (1 trial)

tislelizumab (1 trial)

toripalimab (LOQTORZ) (1 trial)

trastuzumab (herceptin) (1 trial)

vincristine (oncovin) (3 trials)

vitamin d3 (1 trial)

zanubrutinib (Brukinsa) (3 trials)

zimberelimab (1 trial)

[68ga]ga-nota-sna002 (1 trial)

68ga-nodaga-sna006 (1 trial)

afuresertib (1 trial)

alflutinib (1 trial)

autologous fecal microbiota (1 trial)

autologous mesenchymal stem cells (1 trial)

autologous t cells (1 trial)

autologous tumor infiltrating lymphocytes (1 trial)

bone marrow derived mononuclear cells (1 trial)

bronchial basal cells (1 trial)

chlorogenic acid (1 trial)

collagen (1 trial)

ct0591cp (1 trial)

dapagliflozin (farxiga) (1 trial)

ft-003 (1 trial)

gamma-delta t cells (1 trial)

hlx208 (1 trial)

hsk21542 (1 trial)

ibi188 (1 trial)

IBI-346 (1 trial)

ici201 (1 trial)

jaktinib (2 trials)

Larotinib (1 trial)

levothyroxine (Synthroid) (1 trial)

Lisaftoclax (1 trial)

lp-108 (1 trial)

lp-168 (1 trial)

metformin (glucophage) (1 trial)

nbl-012 (1 trial)

omarigliptin (1 trial)

pemetrexed (alimta) (1 trial)

pyroglutamic acid (1 trial)

shr-1314 (1 trial)

sscart-19 cells (1 trial)

tegoprazan (1 trial)

thiscart19 (1 trial)

vicagrel (1 trial)

voriconazole (vfend) (1 trial)

allogeneic lymphocytes (1 trial)

azathioprine (imuran) (1 trial)

b7-h3 target, car gene modified gdt cell injection (1 trial)

camrelizumab (1 trial)

Chiauranib (1 trial)

ct0590 car t cells (1 trial)

ct0594cp (1 trial)

daratumumab (darzalex) (1 trial)

dextrose (1 trial)

epinephrine (levophed) (1 trial)

fenofibrate (fenoglide) (1 trial)

gabapentin (neurontin) (1 trial)

icotinib (Conmana) (1 trial)

il-13 rα2 ucar-t cell injection (1 trial)

indomethacin (indocin) (1 trial)

lactobacillus reuteri (1 trial)

leflunomide (arava) (1 trial)

linaclotide (linzess) (1 trial)

pemigatinib (Pemazyre) (1 trial)

polyethylene glycol (1 trial)

pomalidomide (pomalyst) (1 trial)

pregabalin (lyrica) (1 trial)

vindesine (Eldisine) (1 trial)